Bioresonance therapy unit 20105

With the Rayocomp PS 10 med. treat chronic pain successfully As part of the new clinically prospective, double-blind randomized, placebo-controlled study in Bioresonance according to Paul Schmidt, a special offer was launched by Rayonex Biomedical GmbH: the set purchase of the Rayocomp PS 10 med. The set contains the Rayocomp PS 10 med. and two programmed RAH green cards. One RAH Green Card contains the original study program on HWS syndrome with a duration of just over 2 hours, another RAH Green Card contains the RAH program 70.70 with a treatment duration of 20 minutes. The scope of delivery of the set also includes a fabric detector, designed as fitted sheet. The total price of the set is currently even lower than that of the individual Rayocomp PS 10 med.! Here is information about the Rayocomp PS 10 med. itself: A clinically prospective, double-blind randomized, placebo-controlled study published in the German Register of Clinical Trials (www.drks.de) shows both the enormous efficacy of Rayocomp and its safety in use.